Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-10 4:50 pm Purchase | 13D | Landos Biopharma Inc. LABP | PERCEPTIVE ADVISORS LLC | 1,486,991 47.700% | 1,486,991 (New Position) | View |
| 2024-04-10 4:50 pm Purchase | 13D | Landos Biopharma Inc. LABP | Xontogeny LLC | 309,092 9.900% | 309,092 (New Position) | View |
| 2024-02-14 4:01 pm Sale | 13G | Landos Biopharma Inc. LABP | Bassaganya-Riera Josep | 0 0.000% | -5,720,868 (Position Closed) | View |
| 2023-03-30 5:27 pm Unchanged | 13D | Landos Biopharma Inc. LABP | Xontogeny LLC | 3,090,924 9.900% | 0 (Unchanged) | View |
| 2023-03-30 4:44 pm Unchanged | 13D | Landos Biopharma Inc. LABP | PERCEPTIVE ADVISORS LLC | 14,869,915 47.700% | 0 (Unchanged) | View |
| 2023-02-14 5:00 pm Sale | 13G | Landos Biopharma Inc. LABP | Bassaganya-Riera Josep | 5,720,868 14.200% | -650,000 (-10.20%) | View |
| 2023-01-13 5:07 pm Unchanged | 13D | Landos Biopharma Inc. LABP | PERCEPTIVE ADVISORS LLC | 14,869,915 36.900% | 0 (Unchanged) | View |
| 2022-11-03 4:15 pm Sale | 13D | Landos Biopharma Inc. LABP | RTW INVESTMENTS LP | 0 0.000% | -3,150,722 (Position Closed) | View |
| 2022-10-31 5:05 pm Sale | 13D | Landos Biopharma Inc. LABP | RTW INVESTMENTS LP | 3,150,722 7.830% | -500,000 (-13.70%) | View |
| 2022-10-06 4:30 pm Sale | 13D | Landos Biopharma Inc. LABP | RTW INVESTMENTS LP | 3,650,722 9.070% | -625,000 (-14.62%) | View |
| 2022-08-09 09:19 am Purchase | 13D | Landos Biopharma Inc. LABP | Xontogeny LLC | 3,090,924 7.700% | 3,090,924 (New Position) | View |
| 2022-08-09 09:15 am Sale | 13D | Landos Biopharma Inc. LABP | PERCEPTIVE ADVISORS LLC | 14,869,915 36.900% | -3,090,924 (-17.21%) | View |
| 2022-02-14 5:00 pm Purchase | 13G | Landos Biopharma Inc. LABP | Bassaganya-Riera Josep | 6,370,868 15.800% | 6,370,868 (New Position) | View |
| 2022-02-03 4:49 pm Purchase | 13G | Landos Biopharma Inc. LABP | Osage University GP III LLC | 1,827,478 4.500% | 1,827,478 (New Position) | View |
| 2021-04-06 5:00 pm Unchanged | 13D | Landos Biopharma Inc. LABP | PERCEPTIVE ADVISORS LLC | 17,960,839 44.800% | 0 (Unchanged) | View |
| 2021-02-18 5:15 pm Purchase | 13D | Landos Biopharma Inc. LABP | PERCEPTIVE ADVISORS LLC | 17,960,839 45.900% | 17,960,839 (New Position) | View |
| 2021-02-16 5:23 pm Purchase | 13D | Landos Biopharma Inc. LABP | RTW INVESTMENTS LP | 4,275,722 10.660% | 4,275,722 (New Position) | View |